New Providence Acquisition Corp. III (NPACU) is a focused special purpose acquisition company (SPAC) aimed at identifying and merging with high-potential firms, primarily within the technology and healthcare sectors. Backed by a management team with extensive industry experience, NPACU is dedicated to maximizing shareholder value through strategic acquisitions of businesses demonstrating solid operational performance and significant growth prospects. By employing a rigorous investment strategy, the company is well-positioned to capitalize on emerging market opportunities, ultimately aiming to provide substantial long-term returns to its investors.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.27% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.35 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $28.08M |
| % Insiders | 1.98% |
| % Institutions | 7.12% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NPACU and any ticker you trade — then tracks every position and per-strategy win rate.